Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Mycoses
Hierarchy View
Subtype Terms (20)
Aspergillosis
22 drugs (17 approved, 5 experimental)
Candidiasis
44 drugs (26 approved, 18 experimental)
Central Nervous System Fungal Infections
2 approved drugs
Coccidioidomycosis
11 drugs (8 approved, 3 experimental)
Cryptococcosis
6 drugs (5 approved, 1 experimental)
Dermatomycoses
6 drugs (4 approved, 2 experimental)
Eye Infections, Fungal
3 drugs (2 approved, 1 experimental)
Histoplasmosis
4 approved drugs
Invasive Fungal Infections
19 drugs (12 approved, 7 experimental)
Lung Diseases, Fungal
5 drugs (4 approved, 1 experimental)
Microsporidiosis
1 experimental drug
Otomycosis
7 drugs (2 approved, 5 experimental)
Pneumocystis Infections
4 approved drugs
Zygomycosis
1 approved drug
Phase 1 Indicated Drugs (15)
Organization Involved with Phase 4 Indications (54)
Katholieke Universiteit Leuven
Madrilenian Group of Cutaneous Lymphomas
National Center for Research Resources (NCRR)
National Institute of Allergy and Infectious Diseases (NIAID)
St. Antonius Hospital, Nieuwegein
Taichung Veterans General Hospital
The University of Texas, Dallas
Universidad Autonoma de Madrid
Organization Involved with Phase 3 Indications (54)
Ache Laboratorios Farmaceuticos S.A.
Blood and Marrow Transplant Clinical Trials Network
Center for International Blood and Marrow Transplant Research
European Organisation for Research and Treatment of Cancer
German Society of Hematology and Oncology
Laboratório Teuto Brasileiro S/A
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
Organization Involved with Phase 2 Indications (79)
American Society of Clinical Oncology
Cancer and Leukemia Group B (CALGB)
Cancer Immunotherapy Trials Network
City of Hope National Medical Center
Hoosier Cancer Research Network
James Graham Brown Cancer Center
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Johannes Wesling Klinikum, Minden, Germany
Karl Landsteiner Private University of Health Sciences
Latin American Cooperative Onco-Haematology Group - Peru
Oregon Health and Science University
Rochester Skin Lymphoma Medical Group, PLLC
Shenzhen Geno-Immune Medical Institute
State University of New York, Buffalo
Organization Involved with Phase 1 Indications (27)
Organization Involved with Other Experimental Indications (5)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.